Lars Rebien Sørensen

Lars Rebien Sørensen is a Danish businessman best known for leading Novo Nordisk, a global pharmaceutical company specializing in diabetes care, as its CEO from 2000 to 2016. Under his leadership, the company expanded its focus on innovative diabetes treatments and became one of the world's largest healthcare firms. Sørensen’s strategic decisions helped Novo Nordisk maintain its strong market position and commitment to research and development. He is regarded for his effective leadership, fostering growth, and emphasizing sustainable business practices in the pharmaceutical industry.